Sass F, Ma T, Ekberg J, Kirigiti M, Urena M, Dollet L
Nature. 2024; 635(8040):987-1000.
PMID: 39537932
PMC: 11602716.
DOI: 10.1038/s41586-024-08207-0.
Seminara S, Topaloglu A
J Neuroendocrinol. 2021; 34(5):e13080.
PMID: 34970798
PMC: 9299506.
DOI: 10.1111/jne.13080.
Harris J, Faust B, Gondin A, Damgen M, Suomivuori C, Veldhuis N
Nat Chem Biol. 2021; 18(1):109-115.
PMID: 34711980
PMC: 8712391.
DOI: 10.1038/s41589-021-00890-8.
Rahayu L, Endo N, Kuwai S, Oishi S, Tanaka T
J Reprod Dev. 2019; 65(5):481-484.
PMID: 31406028
PMC: 6815734.
DOI: 10.1262/jrd.2019-038.
Widiapradja A, Chunduri P, Levick S
Cell Mol Life Sci. 2017; 74(11):2019-2038.
PMID: 28097372
PMC: 6339818.
DOI: 10.1007/s00018-017-2452-x.
Substance P Depolarizes Lamprey Spinal Cord Neurons by Inhibiting Background Potassium Channels.
Perez C, Hill R, Grillner S
PLoS One. 2015; 10(7):e0133136.
PMID: 26197458
PMC: 4510128.
DOI: 10.1371/journal.pone.0133136.
Mapping substance P binding sites on the neurokinin-1 receptor using genetic incorporation of a photoreactive amino acid.
Valentin-Hansen L, Park M, Huber T, Grunbeck A, Naganathan S, Schwartz T
J Biol Chem. 2014; 289(26):18045-54.
PMID: 24831006
PMC: 4140293.
DOI: 10.1074/jbc.M113.527085.
Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant.
Szitter I, Pinter E, Perkecz A, Kemeny A, Kun J, Kereskai L
Inflamm Res. 2014; 63(5):399-409.
PMID: 24468892
DOI: 10.1007/s00011-014-0712-x.
New understandings of the genetic basis of isolated idiopathic central hypogonadism.
Bonomi M, Libri D, Guizzardi F, Guarducci E, Maiolo E, Pignatti E
Asian J Androl. 2011; 14(1):49-56.
PMID: 22138902
PMC: 3735150.
DOI: 10.1038/aja.2011.68.
The role of substance P in depression: therapeutic implications.
Schwarz M, Ackenheil M
Dialogues Clin Neurosci. 2011; 4(1):21-9.
PMID: 22033776
PMC: 3181667.
Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.
Douglas S, Leeman S
Ann N Y Acad Sci. 2010; 1217:83-95.
PMID: 21091716
PMC: 3058850.
DOI: 10.1111/j.1749-6632.2010.05826.x.
The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.
Luttichau H
J Biol Chem. 2010; 285(12):9137-46.
PMID: 20044480
PMC: 2838333.
DOI: 10.1074/jbc.M109.002774.
Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.
Gallicchio M, Benetti E, Rosa A, Fantozzi R
Br J Pharmacol. 2009; 156(3):486-96.
PMID: 19154444
PMC: 2697683.
DOI: 10.1111/j.1476-5381.2008.00033.x.
Docking studies suggest ligand-specific delta-opioid receptor conformations.
Micovic V, Ivanovic M, Dosen-Micovic L
J Mol Model. 2008; 15(3):267-80.
PMID: 19052783
DOI: 10.1007/s00894-008-0396-7.
Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits.
Siuciak J, McCarthy S, Martin A, Chapin D, Stock J, Nadeau D
Psychopharmacology (Berl). 2007; 194(2):185-95.
PMID: 17558564
DOI: 10.1007/s00213-007-0828-6.
Characteristics of substance P transport across the blood-brain barrier.
Chappa A, Audus K, Lunte S
Pharm Res. 2006; 23(6):1201-8.
PMID: 16729222
DOI: 10.1007/s11095-006-0068-1.
Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.
Johansson A, Liu L, Holmgren S, Burcher E
Naunyn Schmiedebergs Arch Pharmacol. 2004; 370(1):35-45.
PMID: 15235762
DOI: 10.1007/s00210-004-0943-4.
Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.
Marvizon J, Wang X, Lao L, Song B
Br J Pharmacol. 2003; 140(8):1389-98.
PMID: 14623771
PMC: 1574162.
DOI: 10.1038/sj.bjp.0705578.
Tachykinins via Tachykinin NK(2) receptor activation mediate ozone-induced increase in the permeability of the tracheal mucosa in guinea-pigs.
Fu L, Kaneko T, Ikeda H, Nishiyama H, Suzuki S, Okubo T
Br J Pharmacol. 2002; 135(5):1331-5.
PMID: 11877343
PMC: 1573236.
DOI: 10.1038/sj.bjp.0704572.
Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
Bellucci F, Carini F, Catalani C, Cucchi P, Lecci A, Meini S
Br J Pharmacol. 2002; 135(1):266-74.
PMID: 11786503
PMC: 1573107.
DOI: 10.1038/sj.bjp.0704443.
